From transplants to gene therapy for Parkinson's disease

Experimental Neurology

Volumn 144, Issue 1, 1997, Pages 47-50

  Freeman, Thomas B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE THERAPY; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031105812     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6387     Document Type: Article

References (19)

1. 1. BJORKLUND, A. 1994. Long distance axonal growth in the adult central nervous system. J. Neurol. 241: S33-S35.
2. 2. BJORKLUND, A., O. LINDVALL, O. ISACSON, ET AL. 1987. Mechanisms of action of intracerebral neural implants: Studies on nigral and striatal grafts to the lesioned striatum. Trends Neurosci. 10: 509-516.
3. 3. BRUNDIN, P., R. E. STRECKER, D. J. CLARKE, ET AL. 1988. Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease? Pages 441-448 in D. M. Gash and J. R. Sladek, Eds., Progress in Brain Research, Vol. 78. Elsevier, New York.
4. 4. DIAMOND, S. G., C. H. MARKHAM, AND L. J. TRECIOKAS. 1985. Double-blind trial of pergolide for Parkinson's disease. Neurology 35: 291-295.
5. 5. GORDON, R. 1993. Pages 137-138 in The Alarming History of Medicine. St. Martin's Press, New York.
6. 6. HAYFLICK, L. 1992. Fetal tissue banned ... and used. Science 257: 1027.
7. 7. HORELLOU, P., P. BRUNDIN, P. KALEN, ET AL. 1990. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5: 393-402.
8. 8. KORDOWER, J. H., T. B. FREEMAN, B. J. SNOW, ET AL. 1995. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332: 1118-1124.
9. 9. KORDOWER, J. H., J. M. ROSENSTEIN, T. J. COLLIER, ET AL. 1996. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370: 203-230.
10. 10. KORDOWER, J. H., J. M. ROSENSTEIN, T. J. COLLIER, ET AL. 1996. Functional fetal nigral grafts in two patients with Parkinson's disease. Am. Soc. Neural Transplant. 3: 16.
11. 11. LINDVALL, O. 1991. Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci. 14: 376-384.
12. 12. LINDVALL, O. 1994. Neural transplantation in Parkinson's disease. Pages 103-137 in S. B. Dunnett and A. Bjorklund, Eds., Functional Neural Transplantation. Raven Press, New York.
13. 13. OLANOW, C. W., J. H. KORDOWER, AND T. B. FREEMAN. 1996. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19: 102-109.
14. 14. ROBERTSON, G. S., AND H. A. ROBERTSON. 1989. Evidence that L-Dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J. Neurosci. 9: 3326-3331.
15. 15. SCHNEIDER, J. S., D. S. ROTHBLAT, AND L. DISTEFANO. 1994. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res. 643: 86-91.
16. 16. SCHULTZBERG, M., S. B. DUNNETT, A. BJORKLUND, ET AL. 1984. Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: Evidence for selective growth regulation. Neuroscience 12: 17-32.
17. 17. SENDELBECK, S. L., AND J. URQUHART. 1985. Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion. Brain Res. 328: 251-258.
18. 18. SPENCER, D. D., R. J. ROBBINS, F. NAFTOLIN, ET AL. 1992. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327: 1541-1548.
19. 19. VAN HORNE, C., B. J. HOFFER, I. STROMBERG, I., AND G. A. GERHARDT. 1992. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J. Pharm. Exp. Ther. 263: 1285-1292.